Cayston 75 mg

CAYSTON 75 MG is an inhalation solution containing aztreonam, used to manage chronic pulmonary infections in cystic fibrosis patients. This powder for solution is designed for easy administration via nebulizer.

CAYSTON 75 MG is primarily used for the management of chronic pulmonary infections caused by Pseudomonas aeruginosa in patients with cystic fibrosis. This medication is specifically formulated for inhalation, targeting the lungs directly. It is often prescribed as part of a comprehensive treatment plan to improve respiratory function and reduce infection-related symptoms.

Common effects of CAYSTON 75 MG may include cough, wheezing, and throat irritation. Some users might experience changes in taste or mild respiratory discomfort. These effects are generally temporary and should be discussed with a healthcare provider if they persist or worsen.

CAYSTON 75 MG should be handled with care, ensuring proper storage and preparation of the solution. It is important to follow the prescribed dosage and administration instructions to avoid potential side effects. Patients with known allergies to aztreonam or similar antibiotics should consult their healthcare provider before use.

CAYSTON 75 MG may interact with other medications, particularly those that affect kidney function. It is advisable to inform your healthcare provider about all current medications, including over-the-counter drugs and supplements, to avoid potential interactions. Alcohol and certain foods may also influence the effectiveness of this medication.